XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income $ 36,525 $ 13,360
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 6,805 7,054
Stock-based compensation expense 6,060 3,210
Inventory impairments and abandonments 465 0
Deferred and other income tax expense 11,786 3,942
Gain on sale of fixed assets (170) (111)
Change in allowance for doubtful accounts (60) 5
Equity in income from unconsolidated entities (111) (134)
Cash distributions of income from unconsolidated entities 0 56
Loss on extinguishment of debt, net 563 0
Changes in operating assets and liabilities:    
Decrease in accounts receivable 2,719 5,816
Decrease in income tax receivable 49 315
Increase in inventory (31,231) (89,162)
Decrease in other assets 1,327 3,063
Increase in trade accounts payable 18,440 6,086
(Decrease) increase in other liabilities (3,028) 587
Net cash provided by (used in) operating activities 50,139 (45,913)
Cash flows from investing activities:    
Capital expenditures (6,514) (5,478)
Proceeds from sale of fixed assets 170 136
Net cash used in investing activities (6,344) (5,342)
Cash flows from financing activities:    
Repayment of debt (10,212) (1,150)
Repayment of borrowings from credit facility 0 (95,000)
Borrowings from credit facility 0 345,000
Debt issuance costs (427) 0
Repurchase of common stock 0 (3,327)
Tax payments for stock-based compensation awards (2,620) (2,661)
Stock option exercises and other financing activities 631 (1,854)
Net cash (used in) provided by financing activities (12,628) 241,008
Net increase in cash, cash equivalents, and restricted cash 31,167 189,753
Cash, cash equivalents, and restricted cash at beginning of period 342,528 122,794
Cash, cash equivalents, and restricted cash at end of period $ 373,695 $ 312,547